Description
GDC-0349 is an ATP-competitive inhibitor of mTOR that exhibits anticancer chemotherpeutic activity. GDC-0349 displays pre-clinical efficacy in vitro and in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-0349 is an ATP-competitive inhibitor of mTOR that exhibits anticancer chemotherpeutic activity. GDC-0349 displays pre-clinical efficacy in vitro and in vivo.
Cas No. | 1207360-89-1 |
---|---|
Purity | ≥98% |
Formula | C24H32N6O3 |
Formula Wt. | 452.55 |
Chemical Name | 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-7-(oxetan-3-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
IUPAC Name | 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-7-(oxetan-3-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
Synonym | GDC0349 |
Solubility | DMSO 91 mg/mL (201.08 mM) Ethanol 6 mg/mL (13.25 mM) Water Insoluble |
Appearance | Tan to yellow solid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pei Z, Blackwood E, Liu L, et al. Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349. ACS Med Chem Lett. 2012 Nov 29;4(1):103-7. PMID: 24900569.
Mycotoxin produced by Aspergillus and Penicillu...
Endogenous bombesin-like peptide, involved in f...
SYK/JAK inhibitor
TLR7 agonist
ALK, c-Fes, LRRK2 inhibitor.
Trichothecene mycotoxin produced by Fusarium; p...
Endogenous cardiomodulatory peptide; NPR-A agon...
M4 mAChR agonist, 5-HT1A partial agonist, M1/2/...
NSAID; COX-2 inhibitor.
D-amino acid, incorporated into bacterial cell ...
Thiazide diuretic; NCCT inhibitor, carbonic anh...
PKC activator, carcinogen.
Nav1.7 and Nav1.8 N1+ channel blocker.
AurKA inhibitor.
Nitrobenzene; HPPD inhibitor.
Neuropeptide found in crustaceans and insects.<...
Used to prevent chromium deficiency and to decr...
Bactericidal
Pneumonia antigen
GHB/GABA analog found in Valeriana officinalis;...